Our Services
Medical Information
Helpful Resources
Published on: 9/16/2026
Suddenly stopping metoprolol can cause rebound effects as your body readjusts, including a racing heart, sharply rising blood pressure, palpitations, tremor, sweating, anxiety, and chest pain, typically within the first few days. In people with coronary artery disease, arrhythmias, or heart failure, abrupt discontinuation has been linked to serious events such as angina flares, heart attack, and dangerous rhythm disturbances, which is why clinicians usually taper the dose gradually over one to two weeks. How quickly symptoms appear and how severe they become depends on your dose, how long you have taken it, your underlying heart condition, and other medications you use, so there are several important factors to consider before changing anything, all explained in the complete answer below.
If you have already missed doses or stopped and are noticing a pounding heart, chest discomfort, dizziness, or unusual blood pressure readings, it helps to sort out what is urgent from what can wait for your next appointment. Take a free, instant, online symptom check to see what your symptoms may indicate and get clear guidance on your next steps.
Last reviewed for medical accuracy: 09/15/2026
Metoprolol is a beta-blocker commonly prescribed for high blood pressure, angina (chest pain), heart failure, and after a heart attack. It works by slowing your heart rate and reducing the force of each heartbeat, easing the heart’s workload. Like any medication, metoprolol side effects can occur, ranging from mild (fatigue, dizziness) to serious (low blood pressure, worsening heart failure).
Stopping metoprolol suddenly can trigger a rebound effect—your body has adjusted to the drug’s influence on heart rate and blood vessels, and an abrupt withdrawal can cause these systems to overreact. The results may be uncomfortable or, in some cases, life threatening.
According to the American Heart Association and Mayo Clinic, sudden discontinuation of beta-blockers like metoprolol can lead to:
These effects occur because metoprolol blocks adrenaline’s action on your heart and blood vessels. When the drug is removed without tapering, adrenaline receptors can become hypersensitive, causing your cardiovascular system to go into overdrive.
If you stop taking metoprolol all at once, you might notice symptoms similar to withdrawal. Keep an eye out for:
While not everyone experiences these issues, knowing what to expect can help you recognize early warning signs and seek help promptly.
Medical journals and guidelines report cases where patients who stopped metoprolol suddenly experienced:
The risk is highest in people with existing heart disease, but even those taking metoprolol for high blood pressure or migraine prevention should not stop without a plan.
Never change or stop your metoprolol regimen on your own. Work with your doctor to create a tapering schedule—usually reducing the dose gradually over 1–4 weeks depending on your current dose and health condition. A typical taper might involve:
Your healthcare provider may suggest additional monitoring tools, lifestyle adjustments, or alternative medications as you wean off metoprolol.
If you’ve missed a dose and remember within a few hours, take it as soon as possible. If it’s close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not double up.
If you realize you’ve gone several days without metoprolol, do not restart at your previous dose. Contact your doctor for instructions, or consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to assess your current state and decide if you need urgent care.
Some warning signs require prompt action or emergency services (call 911 in the U.S.):
These could signal a heart attack, stroke, or dangerous arrhythmia triggered by abrupt metoprolol withdrawal.
While tapering off metoprolol, proactive monitoring helps catch problems early:
Regular check-ups and open communication ensure your tapering plan stays safe and effective.
If the goal is to stop metoprolol due to side effects or lifestyle changes, ask your doctor about:
Your provider may refer you to a cardiologist, a pharmacist for medication review, or a nurse educator for detailed guidance.
Stopping metoprolol suddenly can lead to serious complications, even if you feel well. Always:
If you experience any life-threatening symptoms or have concerns about metoprolol side effects, seek medical attention immediately. Open dialogue with your healthcare provider is the best way to ensure a safe transition off metoprolol and maintain your heart health.
Speak to a doctor about any serious or persistent issues—your health and safety depend on it.
(References)
* Beeley L, Talbot J. Beta-blocker withdrawal syndrome? Lancet. 1979 Feb 17;1(8112):387. doi: 10.1016/s0140-6736(79)92931-3. PMID: 85039.
* Botting JH, Gibson A. Beta-blocker withdrawal syndrome. Lancet. 1979 Apr 21;1(8121):875-6. PMID: 86121.
* Entman ML. Alprazolam withdrawal. Tex Med. 1990 Sep;86(9):122. PMID: 2218947.
* Willis MS, Lugo AM. Amiodarone-induced neurotoxicity. Am J Health Syst Pharm. 2009 Mar 15;66(6):567-9. doi: 10.2146/ajhp080196. PMID: 19265185.
* Samuels C, Koenig MK, Hernandez M, Yadav A, Mosquera RA. Mitochondrial Disorder Aggravated by Metoprolol. Case Rep Pediatr. 2016;2016:7869174. doi: 10.1155/2016/7869174. Epub 2016 Oct 20. PMID: 27840760; PMCID: PMC5093265.
* Patel S, Kim S, Allen C. Metoprolol-Induced Pemphigus-Like Reaction. Clin Adv Periodontics. 2019 Mar;9(1):24-28. doi: 10.1002/cap.10044. Epub 2018 Sep 28. PMID: 31490034.
* Glick A, Sista V, Johnson C. Oral Manifestations of Commonly Prescribed Drugs. Am Fam Physician. 2020 Nov 15;102(10):613-621. PMID: 33179891.
* Nishino J, Hu W, Kishtagari A, Shen B, Gao X, Blackman CM, Kassim A, Marneni N, Cherukuri AV, Vittrup R, Kalkan FN, Shah R, Ahn C, Gao A, Ahmedrabie A, Collins RH, Zeidan AM, Bidikian A, Gowda L, Shaffer BC, Madanat YF, Zhao Z, Chung SS, Morrison SJ. Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants. Cancer Discov. 2025 Apr 2;15(4):748-766. doi: 10.1158/2159-8290.CD-24-0719. PMID: 39786370; PMCID: PMC11962394.
* Moreland P, Gaffney B, Lanham JS. Migraine Headache Prophylaxis. Am Fam Physician. 2025 May;111(5):443-450. PMID: 40378325.
* Lewis GD, Garcia-Pavia P, Masri A, Merkely B, Nassif ME, Peña-Peña ML, Barriales-Villa R, Bilen O, Burroughs M, Claggett B, Costabel JP, de Barros Correia E, Dybro AM, Kulac IJ, Lakdawala NK, Mann A, Maron MS, McGinnis S, Nair A, Newlands C, Poulsen SH, Reant P, Schulze PC, Solomon SD, Wang A, Sohn R, Berhane I, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Wohltman A, Fifer MA, Elliott PM, MAPLE-HCM Investigators. Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical Trial. JAMA Cardiol. 2026 Aug 1;11(8):736-746. doi: 10.1001/jamacardio.2026.1730. PMID: 42307914; PMCID: PMC13276672.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.